Edition:
United Kingdom

Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

38.30USD
18 Apr 2019
Change (% chg)

$-0.23 (-0.60%)
Prev Close
$38.53
Open
$38.58
Day's High
$38.68
Day's Low
$37.97
Volume
801,135
Avg. Vol
339,226
52-wk High
$41.52
52-wk Low
$31.95

About

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $8,840.76
Shares Outstanding(Mil.): 230.83
Dividend: --
Yield (%): --

Financials

  QGEN.N Industry Sector
P/E (TTM): 46.98 109.48 62.40
EPS (TTM): 0.82 -- --
ROI: 4.01 7.96 11.78
ROE: 7.36 8.11 12.61

BRIEF-Qiagen And Tecan To Collaborate On Streamline Preanalytical Processing Of QuantiFERON-TB Gold Plus

* QIAGEN AND TECAN ANNOUNCE COLLABORATION TO STREAMLINE PREANALYTICAL PROCESSING OF QUANTIFERON-TB GOLD PLUS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

08 Mar 2019

BRIEF-Qiagen Announces New Collaboration With Novartis

* QIAGEN ANNOUNCES NEW COLLABORATION TO DEVELOP COMPANION DIAGNOSTIC TO GUIDE TREATMENT FOR PATIENTS WITH PIK3CA-MUTATED ADVANCED BREAST CANCER

06 Dec 2018

BRIEF-Blocktrade - Qiagen Bookrunner Says Deal Upsized To $500 Mln On Convertible Notes

* BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS DEAL UPSIZED TO $500M; BOOKS TO CLOSE AT 13.30 UK Source text for Eikon: Further company coverage:

06 Nov 2018

Earnings vs. Estimates